» Articles » PMID: 22321809

Potent Synergistic Effect of IL-3 and TNF on Matrix Metalloproteinase 9 Generation by Human Eosinophils

Overview
Journal Cytokine
Date 2012 Feb 11
PMID 22321809
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

TNF (designated as TNF-α under previous nomenclature) is the preeminent activator of MMP-9 generation from a variety of cells including eosinophils. We have previously established that TNF strongly synergizes with IFN-γ and IL-4 for eosinophil synthesis of Th1- and Th2-type chemokines respectively. Thus, we sought to determine if TNF-induced synthesis of MMP-9 would be enhanced by the presence of Th1, Th2, or the eosinophil-associated common beta chain (βc) cytokines. Human blood eosinophils were cultured with TNF alone or in combination with either IFN-γ, IL-4, IL-3, IL-5, or GM-CSF. Concentrations and activities of MMP-9 in eosinophil culture supernates were measured by ELISA and gelatin zymography, mRNA transcription and stabilization by quantitative real-time PCR, and signaling events by immunoblotting and intracellular flow cytometric analysis. Individually, TNF, GM-CSF, or IL-3, but not IL-4 or IFN-γ, induced relatively small (<0.2 ng/ml) but statistically significant quantities of MMP-9. Remarkable synergistic synthesis of MMP-9 (ng/ml levels) occurred in response to TNF plus IL-3, GM-CSF or IL-5, in the order of IL-3>GM-CSF>IL-5. Zymography revealed that eosinophils release MMP-9 in its pro-form. Eosinophil stimulation with the combination of IL-3 plus TNF led to increased steady-state levels of MMP-9 mRNA, prolonged mRNA stabilization, and enhanced activation of ERK1/2 phosphorylation. Inhibition of NF-κB, MEK kinase, or p38 MAP kinase, but not JNK signaling pathways, diminished IL-3/TNF-induced MMP-9 mRNA and protein production. Thus, the synergistic regulation of eosinophil MMP-9 by IL-3 plus TNF likely involves cooperative interaction of multiple transcription factors downstream from ERK, p38, and NF-κB activation as well as post-transcriptional regulation of MMP-9 mRNA stabilization. Our data indicate that within microenvironments rich in βc-family cytokines and TNF, eosinophils are an important source of proMMP-9 and highlight a previously unrecognized role for synergistic interaction between TNF and βc-family cytokines, particularly IL-3, for proMMP-9 synthesis.

Citing Articles

Advancements in Bullous Pemphigoid Treatment: A Comprehensive Pipeline Update.

Karakioulaki M, Eyerich K, Patsatsi A Am J Clin Dermatol. 2023; 25(2):195-212.

PMID: 38157140 PMC: 10866767. DOI: 10.1007/s40257-023-00832-1.


Bullous pemphigoid-What do we know about the most recent therapies?.

Zeng F, Murrell D Front Med (Lausanne). 2022; 9:1057096.

PMID: 36405625 PMC: 9669062. DOI: 10.3389/fmed.2022.1057096.


Interleukin-26-DNA complexes promote inflammation and dermal-epidermal separation in a modified human cryosection model of bullous pemphigoid.

Mizuno Y, Shibata S, Ito Y, Taira H, Sugimoto E, Awaji K Front Immunol. 2022; 13:1013382.

PMID: 36311716 PMC: 9599390. DOI: 10.3389/fimmu.2022.1013382.


Insights Into the Pathogenesis of Bullous Pemphigoid: The Role of Complement-Independent Mechanisms.

Cole C, Vinay K, Borradori L, Amber K Front Immunol. 2022; 13:912876.

PMID: 35874745 PMC: 9300999. DOI: 10.3389/fimmu.2022.912876.


Eosinophils and melanoma: Implications for immunotherapy.

Robinson I, Santa Lucia G, Li A, Oberholtzer N, Plante J, Quinn K Pigment Cell Melanoma Res. 2021; 35(2):192-202.

PMID: 34927354 PMC: 9012984. DOI: 10.1111/pcmr.13025.


References
1.
de Groot R, Coffer P, Koenderman L . Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family. Cell Signal. 1998; 10(9):619-28. DOI: 10.1016/s0898-6568(98)00023-0. View

2.
Zhao X, Benveniste E . Transcriptional activation of human matrix metalloproteinase-9 gene expression by multiple co-activators. J Mol Biol. 2008; 383(5):945-56. PMC: 2748421. DOI: 10.1016/j.jmb.2008.08.071. View

3.
Kelly E, Busse W, Jarjour N . Increased matrix metalloproteinase-9 in the airway after allergen challenge. Am J Respir Crit Care Med. 2000; 162(3 Pt 1):1157-61. DOI: 10.1164/ajrccm.162.3.9908016. View

4.
Kelly E, Jarjour N . Role of matrix metalloproteinases in asthma. Curr Opin Pulm Med. 2002; 9(1):28-33. DOI: 10.1097/00063198-200301000-00005. View

5.
Hadler-Olsen E, Fadnes B, Sylte I, Uhlin-Hansen L, Winberg J . Regulation of matrix metalloproteinase activity in health and disease. FEBS J. 2010; 278(1):28-45. DOI: 10.1111/j.1742-4658.2010.07920.x. View